Market Cap

UroGen Pharma Ltd. Market Capitalization:

$1.06 Billion

USD as of Jan. 1, 2026

business UroGen Pharma Ltd. Company Profile

UroGen Pharma Ltd. Main Stock Listing

NASDAQ: URGN

Market Capitalization History of UroGen Pharma Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of UroGen Pharma Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.06 B 148.18%
Jan. 1, 2025 $428.3 M 0.48%
Jan. 1, 2024 $426.3 M 112.19%
Jan. 1, 2023 $200.9 M 7.38%
Jan. 1, 2022 $187.1 M -65.02%
Jan. 1, 2021 $534.8 M -24.96%
Jan. 1, 2020 $712.7 M -29.00%
Jan. 1, 2019 $1.00 B -15.68%
Jan. 1, 2018 $1.19 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

UroGen Pharma Ltd. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

UroGen Pharma Ltd. has the following listings and related stock indices.


Stock: NASDAQ: URGN

Stock: FSX: UR8

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.